Ozempic and Wegovy should be covered by Medicare as weight loss treatments: KFF poll

GLP-1 drugs like Ozempic and Wegovy, used for diabetes and heart disease, are now seen as weight loss treatments. Wegovy FDA-approved for weight loss and heart disease.

KFF survey: Only 12% have used GLP-1 drugs, 6% are current users. Young adults use more for weight loss. 61% believe Medicare should cover weight loss drugs.

Read at Fast Company